Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients
{{output}}
Objective: Indacaterol/glycopyrronium (IND/GLY) is a fixed-dose combination (FDC) of indacaterol, an inhaled long-acting β2-agonist (LABA), and glycopyrronium, an inhaled long-acting muscarinic antagonist (LAMA), developed as a ... ...
